Working… Menu

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02632903
Recruitment Status : Withdrawn (While the clinical need for and the scientific merit remain valid, this regulated drug trial was not feasible logistically due to limited funds.)
First Posted : December 17, 2015
Last Update Posted : August 22, 2018
Information provided by (Responsible Party):
Dr. Leanne Ward, Children's Hospital of Eastern Ontario

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2018
Actual Study Completion Date : August 20, 2018